{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Olivas-Aguirre M"],"funding":["Interinstitutional Commission for the Development of Human Resources in Health Sciences","Mexican National Council of Science and Technology","Mexican National Council of Science and Technology (CONACyT) programs"],"pagination":["445"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9856638"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(2)"],"pubmed_abstract":["ALL is a highly aggressive subtype of leukemia that affects children and adults. Glucocorticoids (GCs) are a critical component of the chemotherapeutic strategy against T-ALL. Cases of resistance to GC therapy and recurrent disease require novel strategies to overcome them. The present study analyzed the effects of Dex, one of the main GCs used in ALL treatment, on two T-ALL cell lines: resistant Jurkat and unselected CCRF-CEM, representing a mixture of sensitive and resistant clones. In addition to nuclear targeting, we observed a massive accumulation of Dex in mitochondria. Dex-treated leukemic cells suffered metabolic reprogramming from glycolysis and glutaminolysis towards lipolysis and increased FAO, along with increased membrane polarization and ROS production. Dex provoked mitochond"],"journal":["Cancers"],"pubmed_title":["Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance."],"pmcid":["PMC9856638"],"funding_grant_id":["CF-2019 21887","FOP02-2022-02 321696","PRONACES #303072"],"pubmed_authors":["Dobrovinskaya O","Olivas-Aguirre M","Torres-Lopez L","Hernandez-Cruz A","Pottosin I","Perez-Chavez J"],"additional_accession":[]},"is_claimable":false,"name":"Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance.","description":"ALL is a highly aggressive subtype of leukemia that affects children and adults. Glucocorticoids (GCs) are a critical component of the chemotherapeutic strategy against T-ALL. Cases of resistance to GC therapy and recurrent disease require novel strategies to overcome them. The present study analyzed the effects of Dex, one of the main GCs used in ALL treatment, on two T-ALL cell lines: resistant Jurkat and unselected CCRF-CEM, representing a mixture of sensitive and resistant clones. In addition to nuclear targeting, we observed a massive accumulation of Dex in mitochondria. Dex-treated leukemic cells suffered metabolic reprogramming from glycolysis and glutaminolysis towards lipolysis and increased FAO, along with increased membrane polarization and ROS production. Dex provoked mitochond","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2026-06-21T03:14:33.686Z","creation":"2026-06-21T03:10:49.609Z"},"accession":"S-EPMC9856638","cross_references":{"pubmed":["36672393"],"doi":["10.3390/cancers15020445"]}}